工程APTAMER导向的酸酶招募仿真体:调节受体功能和克服药物耐药性的策略
Zhilan Zhou1,2, Yichang Liu3, Ya Wang2
1Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300072, China.
Nature communications
|April 25, 2025
概括
我们开发了Aptamer指导的酸酶招募基因组 (Apt-PRCs) 来去化细胞表面受体,通过向受体氨酸激酶来克服癌症药物耐药性的新策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 受体氨酸激酶 (RTK) 在细胞信号传递和癌症发育中至关重要.
- 目前的激酶抑制剂面临的挑战是异于目标效应和耐药性.
- 需要新的策略来有效调节RTK功能.
研究的目的:
- 为了开发一种新的方法,Aptamer指导的酸酶招募奇默体 (Apt-PRCs),用于减弱细胞表面受体信号传递.
- 证明Apt-PRCs在去化EGFR和MET等特定RTK的有效性.
- 评估APT-PRCs在克服癌症中耐药性的潜力.
主要方法:
- 设计和制造Apt-PRCs,包括用于酸酶招募的aptamer和用于受体向的绑定剂.
- 在体外和体内实验中评估Apt-PRCs的脱酸化活性和信号抑制.
- 在耐药癌症模型中评估Apt-PRC在增强对gefitinib敏感性的疗效.
主要成果:
- Apt-PRCs成功地实现了目标RTK (EGFR,MET) 的直接脱化.
- Apt-PRCs证明了酸化信号接收和传输的特定和有效抑制.
- 由Apt-PRCs诱导的脱化增强了耐药癌细胞和小鼠模型中gefitinib的敏感性.
结论:
- Apt-PRCs代表了调节受体酸化和下游信号的多功能方法.
- 这种方法显示出在癌症治疗中克服耐药性的巨大潜力.
- 适用PRC为针对RTK信号通路提供了一个有希望的替代策略.
更多相关视频
03:38Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
1.3K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
